NBOMes

General Information

Classification: Psychedelic (with reported stimulating properties)

History

These chemicals have nearly no history of human use prior to 2010 when they first became available online.

25i-NBOMe Dosage

Effects have been reported to vary very strongly by person (for example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect).

Oral

Duration: 4-14 hours

Low dose: 200-500 ug (micrograms!)

Medium (typical) dose: 500-1500 ug (micrograms!)

High dose: >1500 ug (micrograms!)

Insufflated

Duration: X hours

Onset: X minutes

Low dose: X mg

Medium (typical) dose: X mg

High dose: X mg

25c-NBOMe Dosage

Effects have been reported to vary very strongly by person (for example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect).

Oral

Duration: 4-11 hours

Low dose: X ug (micrograms!)

Medium (typical) dose: X ug (micrograms!)

High dose: X ug (micrograms!)

Insufflated

Duration: 3-8 hours

Onset: 0-10 minutes

Low dose: 100-300 ug (micrograms!)

Medium (typical) dose: 300-500 ug (micrograms!)

High dose: >500 ug (micrograms!)

Effects

After effects

• "Hangover"?

• Afterglow

• Long term effects

Harm Reduction

• Avoid driving and operating heavy machinery

• Recommended time (pauses) between using the substance

• Addiction potential?

• Risk of death?

• Mental illness?

• Heart issues?

Images

• 

  italic caption

• 
• 
• 
• 

Legal

Europe

The -NBOMe series of psychoactives became controlled in the Russian Federation starting October, 2011. See http://www.rg.ru/2011/10/19/narko-dok.html

America

The NBOMe series of compounds are unscheduled in the United States. It is possible that some of them would be considered analogs (of scheduled phenethylamines such as 2C-B or mescaline), in which case, sales for human consumption or possession with the intent to ingest could be prosecuted under the Federal Analogue Act. However, Virginia has recently made the 25x-NBOMe series and all its analogues schedule I; expected is that more states are to follow quickly.